These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 18894887)
1. Studies on the laxative activity of triphenylmethane derivatives; relationship between structure and activity of phenolphthalein congeners. LOEWE S J Pharmacol Exp Ther; 1948 Nov; 94(3):288-98. PubMed ID: 18894887 [No Abstract] [Full Text] [Related]
2. Studies on the laxative activity of triphenylmethane derivatives; physicochemical aspects of the potency difference between yellow phenolphthalein and U.S.P. phenolphthalein. LOEWE S; LOEWE IA Arch Int Pharmacodyn Ther; 1949 Aug; 80(2-3):236-45. PubMed ID: 18137859 [No Abstract] [Full Text] [Related]
3. Studies on the laxative activity of triphenylmethane derivatives; physical characteristics of phenolphthalein in relation to yellow phenolphthalein activation. LOEWE S; LOEWE IA Arch Int Pharmacodyn Ther; 1949 Aug; 80(2-3):246-54. PubMed ID: 18137860 [No Abstract] [Full Text] [Related]
4. Studies on the laxative activity of triphenylmethane derivative; the relation between water-repellency and activation of phenolphthalein preparations and the concept of floto activation. LOEWE S; LOEWE IA Arch Int Pharmacodyn Ther; 1950 Feb; 81(2):195-206. PubMed ID: 15410271 [No Abstract] [Full Text] [Related]
5. [THE LAXATIVE ACTION OF SOME TRIPHENYLMETHANE DERIVATIVES]. HACKENTHAL E; STUTTE HJ; JUNGMANN B Arzneimittelforschung; 1963 Aug; 13():657-60. PubMed ID: 14090433 [No Abstract] [Full Text] [Related]
6. Effect of three laxatives and a cation exchange resin on fecal sodium and potassium excretion. Emmett M; Hootkins RE; Fine KD; Santa Ana CA; Porter JL; Fordtran JS Gastroenterology; 1995 Mar; 108(3):752-60. PubMed ID: 7875477 [TBL] [Abstract][Full Text] [Related]
7. Risk of ovarian cancer in relation to use of phenolphthalein-containing laxatives. Cooper GS; Longnecker MP; Sandler DP; Ness RB Br J Cancer; 2000 Aug; 83(3):404-6. PubMed ID: 10917559 [TBL] [Abstract][Full Text] [Related]
8. Phenolphthalein-containing laxative use in relation to adenomatous colorectal polyps in three studies. Longnecker MP; Sandler DP; Haile RW; Sandler RS Environ Health Perspect; 1997 Nov; 105(11):1210-2. PubMed ID: 9370521 [TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer risk and use of phenolphthalein-containing laxatives. Cooper GS; Longnecker MP; Peters RK Pharmacoepidemiol Drug Saf; 2004 Jan; 13(1):35-9. PubMed ID: 14971121 [TBL] [Abstract][Full Text] [Related]
10. [Are anthraquinone laxatives transferred to breast milk?]. FRIEBEL H; WALKOWIAK L Med Klin; 1951 Feb; 46(7):208-9. PubMed ID: 14842489 [No Abstract] [Full Text] [Related]
11. Laxative use not a risk for colorectal cancer: data from the Melbourne Colorectal Cancer Study. Kune GA Z Gastroenterol; 1993 Feb; 31(2):140-3. PubMed ID: 8465555 [TBL] [Abstract][Full Text] [Related]
12. Laxatives: chemical structure and potency of phthaleins and hydroxyanthraquinones. HUBACHER MH; DOERNBERG S; HORNER A J Am Pharm Assoc Am Pharm Assoc; 1953 Jan; 42(1):23-30. PubMed ID: 13034620 [No Abstract] [Full Text] [Related]
13. Nitric oxide as a mediator of bisacodyl and phenolphthalein laxative action: induction of nitric oxide synthase. Gaginella TS; Mascolo N; Izzo AA; Autore G; Capasso F J Pharmacol Exp Ther; 1994 Sep; 270(3):1239-45. PubMed ID: 7523656 [TBL] [Abstract][Full Text] [Related]
14. In vivo estrogenic and antiestrogenic activity of phenolphthalein and derivative compounds. Nieto A; García C; López de Haro MS Biochem Int; 1990; 21(2):305-11. PubMed ID: 2403370 [TBL] [Abstract][Full Text] [Related]